Meanwhile, the BSE Sensex was up 25.71 points, or 0.14%, to 18,748.01.
On BSE, 1,120 shares were traded in the counter as against an average daily volume of 8,234 shares in the past one quarter.
The stock hit a high of Rs 111 and a low of Rs 108.80 so far during the day. The stock had hit a record high of Rs 399.95 on 10 November 2010 and a 52-week low of Rs 82 on 24 June 2011.
The small-cap stock had outperformed the market over the past one month till 22 July 2011, gaining 25.58% compared with the Sensex's return of 6.68%. The scrip had, however, underperformed the market in past one quarter, falling 41.30% as against 4.49% decline in the Sensex.
The company has an equity capital of Rs 25.87 crore. Face value per share is Rs 10.
Parenteral Drugs (India)'s net sales declined 54.14% to Rs 45.29 crore in Q1 June 2011 over Q1 June 2010. The company announced the results on Saturday, 23 July 2011.
Parenteral Drugs (India) is involved in research, production and manufacturing of pharmaceutical products viz. intravenous infusion, tablets, capsules, liquids syrups and injections.